How many investments has Tramway Venture Partners made?

Tramway Venture Partners has 6 tracked investments.

What stage does Tramway Venture Partners invest at?

Tramway Venture Partners invests at the Seed, Series A stages.

What is Tramway Venture Partners's typical check size?

Tramway Venture Partners typically writes checks of $30M.

What sectors does Tramway Venture Partners focus on?

Tramway Venture Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.

Where is Tramway Venture Partners located?

Tramway Venture Partners is headquartered in New Mexico, US.

Who does Tramway Venture Partners co-invest with?

Tramway Venture Partners most often shares deals with Cottonwood Technology Fund, Felicis Ventures, Houston Angel Network, among 4 tracked co-investors.

Tramway Venture Partners

Venture capital

New Mexico · Seed–Series A · 8 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

The firm invests in life sciences, using the technology-rich Southwestern United States, and particularly New Mexico, as its base for building disruptive life science companies. It emphasizes finding opportunities in out-of-the-way places where competition may be lower and untapped potential exists.

Invests inBiotech Deep Tech Digital Health Healthtech Medical Devices Albuquerque United States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Check

$30M

New Mexico, New Mexico, US

Instruments

Equity

Founded

2017

Last 12 months

4 investments

Tracked investments

Team · 8 people

from the firm's website & public directories

Waneta Tuttle· Founder and Managing Partner· New Mexicoin

Waneta Tuttle focuses on the intersection of technology and health care. She holds a PhD and an MBA, has founded six companies, and has served on the boards of organizations ranging from startups to a publicly traded pharmaceutical company and one of the largest U.S. health insurers.

Chris Japp· Managing Partner· Santa Fe, New Mexicoin

Chris Japp is a C-suite executive with over 30 years of global experience in healthcare technology, having held senior leadership roles at large multinational companies and gained corporate M&A experience across multiple clinical fields. He has served in non-executive board positions and has experience with early-stage company development and operations. He holds a BS in Electrical Engineering from Queen's University in Canada.

Katie Rice· Managing Partner· Albuquerque, New Mexicoin

Katie Rice is a venture investor and entrepreneur who, before Tramway, ran the New Mexico office of Utah-based Epic Ventures, where she backed more than a dozen early-stage technology and software companies. She founded the Ski Lift Pitch event and co-founded BabyPages Inc., a New Mexico startup where she serves as CEO. She earned a bachelor's degree in Materials Science and Engineering from MIT and an MBA from the University of Chicago.

Joseph Juang· Principal· New Mexico

Focused on the digitization of healthcare, Joseph previously worked at Tullis Health Investors and Cultivation Capital and has life science research experience. He holds an MBA from Washington University in St. Louis and a BS in Biology from Purdue University.

j•••@tramwayventures.comreveal

Brad H. Vale· Venture Partner· Minden, Nevada, United Statesin

Founding General Partner of Treo Ventures who previously led JJDC, Johnson & Johnson's venture arm.

b•••@treovp.comreveal

John Rockwell· Venture Partner· New Mexicoin

John Rockwell is a Venture Partner at Tramway Venture Partners with a background in physics and engineering. He served as an officer in the US Air Force working on R&D for large laser systems, landing gear, and cryogenic coolers, and later became an executive at Chromex, a manufacturer of Raman spectrometers. He subsequently spent about two decades running Marpac, a medical device manufacturer, and Sierra Peaks, an engineering firm, both of which he recently sold.

Stu Rose· Venture Partner· New Mexico

Stu Rose is a Venture Partner at Tramway Venture Partners who contributes to the firm's deal sourcing and brings business and investment experience along with a network across New Mexico. He holds a PhD in chemistry, has an entrepreneurial background having started more than ten companies, and is recognized for expertise in pharmaceutical manufacturing. He founded The BioScience Center in Albuquerque and FatPipe ABQ, a network of co-working spaces in New Mexico.

Dee Brescia· Administrative Services

CEO of Brescia Consulting with decades of experience providing financial management and administrative services to start-up life sciences companies and investment groups; supports Tramway's fund reporting and investment tracking.

What they invest in

from 10 of 16 portfolio companies

Biotech ×6Energy ×3Medical Devices ×2AI & Machine Learning ×1Cleantech ×1Climate Tech ×1Digital Health ×1Hardware ×1

HQs:United States×11

Investments · 16 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 4 2024 · 1 2023 · 1 2020 · 1 2018 · 1 2015 · 110 dated

AgilVaxagilvax.comApr 2018SEC filinghigh confidence

BiotechAlbuquerque, US

Joseph Patti(Executive Officer, Director)Ebetuel Pallares(Executive Officer, Director)Faith Charles(Director)Debora E Ramirez(Executive Officer)Bill Enloe(Director)Stuart Rose(Director)

Board seatWaneta Tuttle· per SEC Form D · $7.5M raise · filed Aug 2019

Armonica Technologiesarmonicatech.comDec 2025

BiotechAlbuquerque, US

Stephen Brueck(Executive Officer, Promoter)Emily Milsovic(Executive Officer, Director)Steven R.J. Brueck(Director)Scott L. Goldman(Executive Officer, Director, Promoter)Zachary Lerner(Executive Officer)

BoardDavid Blivin(Director)in

Board seatWaneta Tuttle· per SEC Form D

Co-investorsCottonwood Technology Fund Sun Mountain Capital 8VC Alumni Ventures Durable Capital Partners Lockheed Martin Ventures +2 more

Carbon Capture AmericaMar 2020SEC filingmedium confidence

EnergyArvada, US

Brent Lewis(Executive Officer, Director)Scott Frazier(Executive Officer, Director)Alex Lau(Director)

Board seatJohn Rockwell· per SEC Form D · $4M raise · filed Mar 2020

Circular Genomicscirculargenomics.com in 𝕏Jan 2024 · $8.3M

Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.

AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US

Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)

Board seatWaneta Tuttle· per SEC Form D

Co-investorsCottonwood Technology Fund Mountain Group Capital

FrostCarbonfrostcarbon.comAug 2025SEC filingmedium confidence

FrostCarbon develops FrostCC®, a patented cryogenic carbon capture system that uses a thermomechanical "compress, frost, melt" process to capture CO₂ from power plants, industrial facilities, and pulp & paper mills.

CleantechClimate TechEnergyDover, US

Miles Abarr(Executive Officer, Director)Brent Lewis(Executive Officer, Director)

BoardJason Williams(Director)Alex Lau(Director)

Board seatJohn Rockwell· per SEC Form D · $2.3M raise · filed Sep 2025

HiQ Solar inJul 2015SEC filingmedium confidence

EnergySanta Clara, US

Andre Willis(Executive Officer, Director)Lutz Henckels(Executive Officer, Director)

BoardAngiolo Laviziano(Director)Chuck Abronson(Director)John Hall(Director)

Board seatJohn Rockwell· per SEC Form D · $11.1M raise · filed Sep 2015

ORBION SPACE TECHNOLOGY, INC.Dec 2025SEC filingmedium confidence

Houghton, US

Lyon B. King(Executive Officer, Director)Jason Sommerville(Director)Jorge Ramos(Director)

BoardKanwal Rekhi(Director)inAdam Sharkawy(Director)in

Board seatJohn Rockwell· per SEC Form D · $37.1M raise · filed Dec 2025

Co-investorsInventus Capital Partners Material Impact

Vitazi.AI, Inc.Feb 2026SEC filingmedium confidence

BiotechSanta Fe, US

Davin Isakson(Executive Officer)Alan Nolley(Executive Officer, Director, Promoter)Jeremy Stueven(Executive Officer, Director, Promoter)Nathan Wyatt(Executive Officer)Jeffrey Wigdahl(Executive Officer)Sydnie Keddington(Director)

Board seatWaneta Tuttle· per SEC Form D · $3M raise · filed Feb 2026

WaveFront Dynamics Inc.wavefrontdynamics.com inSep 2023

Wavefront Dynamics is a medical device company that develops diagnostic and lens design systems for vision care, built on Shack-Hartmann wavefront sensor technology.

BiotechHardwareHealthtechMedical DevicesAlbuquerque, US

Daniel R. Neal(Executive Officer, Director, Promoter)Dan Neal(Founder & CEO)R. Terry Dunlay(Director)

Board seatWaneta Tuttle· per SEC Form D

Co-investorsPhoenix Venture Partners

BennuBiobennubio.com

Online gambling platform offering slots, live-dealer table games, crash-style games, and sports betting to players in Azerbaijan.

BiotechAlbuquerque, US

Travis Woods(Executive Officer)Steven Graves(Executive Officer, Director, Promoter)R. Terry Dunlay(Director)James Freyer(Executive Officer)

BoardWaneta Tuttle(Director)inSally Corning(Director)

Co-investorsCottonwood Technology Fund Sun Mountain Capital

Breezy Med

Automated, data-driven biohazard disinfection platform field-tested across multiple industries.

Daisyjoindaisy.com inDec 2025 · $2.5M

Daisy is a full-service property management company for condos, co-ops, and HOAs, combining on-site management teams with a unified operating system for building operations, finances, maintenance, and compliance projects like FISP and Local Law 97.

PropTechSaaS

Co-investorsFinTech Collective Cottonwood Technology Fund Ev3 Ventures Llc Framework Venture Partners Sonae IM VOLT CAPITAL

Daisy Genomics

Developing advanced nanochip systems for direct reading of DNA and study of single-cell epigenetics.

Epistemix

Develops proprietary synthetic population models and simulation engines for predictive forecasting and decision-making.

Co-investorsFelicis Ventures Signal Peak Ventures

Nob Hill Therapeuticsnobhilltherapeutics.com in

Albuquerque, US

Noel Greenberger(Executive Officer, Director)Yun Li(Executive Officer, Director)

BoardChris Japp(Director)inPaul Atkins(Director)Robert Calvin Goforth(Director)

Co-investorsHouston Angel Network

WavDyn

Developing instruments for ophthalmology to measure and improve visual performance.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Top Startup and Tech Funding News – January 5, 2025 - Tech Startups

Armonica Technologies · techstartups.com · Jan 6, 2026

Daisy Genomics Raises $2.5M in Seed Funding to Develop Optical Long-Read Sequencing Tech | GenomeWeb

Daisy · genomeweb.com · Dec 17, 2025

Circular Genomics Raises $15M in Series A Funding

Circular Genomics · finsmes.com · Dec 1, 2025

News & Events - WaveFront Dynamics

WaveFront Dynamics Inc. · wavefrontdynamics.com · Oct 22, 2025

Albuquerque-based company BennuBio acquired by California firm

BennuBio · finance.yahoo.com · Oct 9, 2025

Frequently asked questions

How many investments has Tramway Venture Partners made?: Tramway Venture Partners has 6 tracked investments.
What stage does Tramway Venture Partners invest at?: Tramway Venture Partners invests at the Seed, Series A stages.
What is Tramway Venture Partners's typical check size?: Tramway Venture Partners typically writes checks of $30M.
What sectors does Tramway Venture Partners focus on?: Tramway Venture Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
Where is Tramway Venture Partners located?: Tramway Venture Partners is headquartered in New Mexico, US.
Who does Tramway Venture Partners co-invest with?: Tramway Venture Partners most often shares deals with Cottonwood Technology Fund, Felicis Ventures, Houston Angel Network, among 4 tracked co-investors.

Images

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M